Important Catalysts For 3 Biotech Companies
By LifeSci Advisors : By George Dimopoulos, Ph.D. And Jerry Isaacson, Ph.D. This note is part of our ongoing efforts to highlight interesting binary events for small-cap biotechnology companies. Here we discuss the upcoming FDA panel meeting and PDUFA date for Zogenix's ( ZGNX ) experimental pain ...
Read the rest of this article on Healthcare Sector and Stocks Analysis from Seeking Alpha
Related Videos
-
No Sign of Slowdown in Biotech M&AHigh levels of merger and acquisition activity will be the big theme of year for biotech , says Morningstar's Lauren Migliore.
-
Our Top Five Biotech Acquisition CandidatesM&A activity grew in 2010, and we expect deal volume to remain strong in 2011.
-
Top Biotech Acquisition Candidates2011 was a relatively light year for biotech M&A, but it looks like activity is picking up in 2012.
-
Our Top Five Biotech Takeout PicksHealth-care analyst Lauren Migliore looks at what makes a biotech firm a likely takeout candidate and reveals our top five biotech M&A picks for 2010.